| Tuesday, 27 October 2015 - Pre-conference courses | Wednesday, 28 October 2015 | Thursday, 29 October 2015 |
| Friday, 30 October 2015 | Detailed List of Posters |
Conference day 1 - Wednesday, 28 October 2015
| Zenit | Nadir | ||||
| 08:00 - 09:00 | Registration | ||||
| 09:00 - 09:30 | Opening Ceremony | ||||
| 09:30 - 10:30 |
Opening
Lecture / CIOMS Keynote Lecture
Chair: Gunilla Sjölin-Forsberg (Switzerland) O 33: Beyond Protection: The Integrity of Science as a Fundamental Ethical Concern Speaker: Alex John London (USA) |
||||
| 10:30 - 11:00 | Coffee Break and Poster viewing | ||||
| 11:00 - 11:45 |
Keynote
Lecture 1 Chair: Jan Petráček (Czech Republic) O 02: The Future of pharmacovigilance Speaker: Peter Arlett (UK) |
||||
| 11:45 - 12:30 |
Keynote
Lecture 2
Chair: Gunilla Sjölin-Forsberg (Switzerland) O 03: Big data including social media. Global perspectives Speaker: Marie Lindquist (Sweden) |
||||
| 12:30 - 14:00 | Lunch | ||||
| 14:00 - 15:30 |
Parallel
session A Risk Management in Pharmacotherapy Chairs: Jan Petráček (Czech Republic), Ghita Benabdallah (Morocco) |
14:00 - 15:30 |
Parallel
session B Vaccines Chairs: Gunilla Sjölin-Forsberg (Switzerland), Tatiana Belkina (Czech Republic) |
||
| 14:00 - 14:20 |
O 04:
Medication errors – EU regulatory initiatives on risk minimisation and
error prevention Speaker: Thomas Goedecke (UK) |
14:00 - 14:30 |
O 09:
Methodologies for vaccine safety surveillance Speaker: Nick Andrews (UK) |
||
| 14:20 - 14:40 |
O 05:
WHO guideline: Reporting and learning systems for medication errors:
the role of pharmacovigilance centres Speaker: Ghita Benabdallah (Morocco) |
14:30 - 14:45 |
O 10:
Signal detection methods for vaccine spontaneous report data Speaker: Lionel Van Holle (Belgium) |
||
| 14:40 - 15:00 |
O 06:
Patient adherence and patient safety Speaker: Bernard Vrijens (Belgium) |
14:45 - 15:00 |
O 11:
Monitoring adverse events following influenza vaccination in general
practice: Evaluation of different methods to increase the inclusion
rate of patients Speaker: Leontine van Balveren (The Netherlands) |
||
| 15:00 - 15:15 |
O 07:
Evaluating prescriber concordance with prescribing: results from a
post-marketing study in primary care setting Speaker: Saad Shakir (UK) |
15:00 - 15:15 |
O 12:
Identification of vaccine safety signals in VigiBase Speaker: Rebecca Chandler (Sweden) |
||
| 15:15 - 15:30 |
O 08:
Medication errors detected among the spontaneously reported adverse
drug reactions to the Croatian Agency for Medicinal Products and
Medical Devices Speaker: Viola Macolić Šarinić (Croatia) |
15:15 - 15:30 |
O 13:
Asymptomatic Immunization errors reporting in Morocco Speaker: Amina Tebaa (Morocco) |
||
| 15:30 - 16:00 | Coffee Break and Poster viewing | ||||
| 16:00 - 17:30 |
Parallel
session C Risks and benefits of medicines for women Chairs: Mira Harrison-Woolrych (UK), Jiří Vlček (Czech Republic) |
16:00 - 17:30 |
Parallel
session D Benefit/Burden of pharmacovigilance Chairs: Marco Tuccori (Italy), Veronique Kugener (USA) |
||
| 16:00 - 16:30 |
O 14:
Medicines for Women: Medicines for Half the World Speaker: Mira Harrison-Woolrych (UK) |
16:00 - 16:30 |
O 19:
Another perspective in pharmacovigilance Speaker: Eugene van Puijenbroek (The Netherlands) |
||
| 16:30 - 16:45 |
O 15:
Evidence-based use of menopausal hormone therapy Speaker: Emily Banks (Australia) |
16:30 - 16:45 | Panel discussion | ||
| 16:45 - 17:00 |
O 16:
Safety of medicines during breastfeeding Speaker: Eva Jirsová (Czech Republic) |
16:45 - 17:00 |
O 20: An Assessment of
Utility and Burden Associated with the Vandetanib (CAPRELSA®)
Restricted Distribution Program in Canada Speaker: Yola Moride (Canada) |
||
| 17:00 - 17:15 |
O 17:
A woman is not like a man: why risk communication for women is a whole
new game Speaker: Bruce Hugman (Sweden) |
17:00 - 17:15 |
O 21:
Building Up a Signal Management Framework For a Resource-limited Health
Authority Speaker: Wen-Wen Chen (Taiwan Republic of China) |
||
| 17:15 - 17:30 |
Discussion |
17:15 - 17:30 |
O 59:
Estimation of theoretical cost preventability achievable with an
effective pharmacovigilance activity in a Pharmacovigilance Regional
Centre in Italy Speaker: Alice Capogrosso Sansone (Italy) |
||
| 17:30 - 19:00 | Chapters meeting | 17:30 - 19:00 | CommSIG meeting | ||
Conference day 2 - Thursday, 29 October 2015
| Zenit | Nadir | ||||
| 08:30 - 10:15 |
Parallel
session E The roles of PV centers and community involvement Chairs: Everardo Vazquez (Mexico), Veronika Deščíková (Czech Republic) |
08:30 - 10:15 |
Parallel
session F Emerging sources of PV data Chairs: Yola Moride (Canada), Martin Votava (Czech Republic) |
||
| 08:30 - 09:00 |
O 22:
Patients involvement for a better PV knowledge Speaker: Linda Härmark (The Netherlands) |
08:30 - 09:00 |
O 27: Use of social media
for data mining in pharmacovigilance Speaker: Nabarun Dasgupta (USA) |
||
| 09:00 - 09:30 |
O 23:
Coordinating the WHO Drug Monitoring Programme: the role of WHO
Collaborating Centres Speaker: Clive Ondari (Switzerland) |
09:00 - 09:15 |
O 28: Integrating
Pharmacogenomics with Pharmacovigilance - Croatian Experience Speaker: Viola Macolić Šarinić (Croatia) |
||
| 09:30 - 09:45 |
O 24:
Knowledge about adverse drug reaction and reporting among the
healthcare professionals in Bhutan Speaker: Choki Dorji (Bhutan) |
09:15 - 09:30 |
O 29:
Factors influencing adverse drug reactions reporting by patients – a
cross-sectional study from Bulgaria Speaker: Hristina Lebanova (Bulgaria) |
||
| 09:45 - 10:00 |
O 25:
The impact of ADRs on patient’s quality of life after packaging changes
of the drug Thyrax® Speaker: Leàn Rolfes (The Netherlands) |
09:30 - 09:45 |
O 30:
Adverse Drugs Reactions (ADR) collected by Medical Staffed
Ambulances: pilot study Speaker: Agnès Lillo-Le Louët (France) |
||
| 09:45 - 10:00 |
O 31:
The effect of regulatory definitions on mining social media for adverse
events: A real-world examination Speaker: Michael Ibara (USA) |
||||
| 10:00 - 10:15 |
O 26:
Enforcing the habit – the role of champions in pharmacovigilance
education Speaker: Karamjit Khangura (UK) |
10:00 - 10:15 |
O 32:
Exploiting Heterogeneous Open Data for Pharmacovigilance Speaker: Vassilis Koutkias (France) |
||
| 10:15 - 10:45 | Coffee Break and Poster viewing | ||||
| 10:45 - 11:45 |
Keynote
Lecture 3 Chair: Jan Petráček (Czech Republic) O 01: Patient Safety Today – From Identifying Problems to Implementing Solutions Speaker: Nick Sevdalis (UK) |
||||
| 11:45 - 12:45 | Lunch | ||||
| 12:45 - 14:45 | ISoP General Assembly and Presentation ISoP Annual Meeting 2016 | ||||
| 14:45 - 16:15 |
O 34:
PRAC session and Round-table discussion
Chairs: Hervé Le Louët (France), June Raine (UK) |
||||
| 14:45 - 15:00 |
Progress in 3 years of
pharmacovigilance in EU – key success factors and ongoing challenges
Speaker: Peter Arlett (UK) |
||||
| 15:00 - 15:15 |
Perspective from a member
state on PRAC delivering strengthened public health protection
Speaker: Jana Mladá (Czech Republic) |
||||
| 15:15 - 15:30 |
PRAC’s best evidence in
pharmacovigilance strategy
Speaker: Dolores Montero (Spain) |
||||
| 15:30 - 15:45 |
Key improvements for PRAC
moving forward
Speaker: June Raine (UK) |
||||
| 15:45 - 16:15 | Round-table / Panel discussion | ||||
| 16:15 - 16:45 | Coffee Break and Poster viewing | ||||
| 16:45 - 18:00 |
Parallel
session G Hospital Pharmacovigilance, ADR reporting in patients and Clinical Epidemiology Chairs: Victoria Rollason (Switzerland), Ulrich Hagemann (Germany) |
16:45 - 18:00 |
Parallel
session H Herbals Chairs: Souad Skalli (Morocco), Marie Heroutová (Czech Republic) |
||
| 16:45 - 17:00 |
O
35: US health care professional perspectives on adverse drug
event reporting in the hospital setting and the opportunity for
information technology Speaker: Gustavo Grampp (USA) |
16:45 - 17:15 |
O 39:
Do we need new and specific methods for PV of herbal medicines? Speaker: Souad Skalli (Morocco) |
||
| 17:00 - 17:15 |
O 36:
Triggers of Active Surveillance of Adverse Drug Events in Hospitalized
Newborns: A Pilot Study Speaker: Sandra Carvalho Fabretti (Brazil) |
17:15 - 17:30 |
O 40:
Impediments in the monitoring of drugs of Traditional system of Medicine Speaker: K. C. Singhal (India) |
||
| 17:15 - 17:30 |
O 37:
Strategies for detection adverse drug reactions – comparison of
hospital database and spontaneous reporting Speaker: Joana Marques (Portugal) |
17:30 - 17:45 |
O 58:
Dietary Supplements Used In Bodybuilding: Possible Serious Adverse
Effects Speaker: Louise Gaboriau (France) |
||
| 17:30 - 17:45 |
O 38:
Implementation of pharmacovigilance in clinical sitting: national
oncology institute experience Speaker: Houda Sefiani (Morocco) |
17:45 - 18:00 |
O 42:
Safety of red rice yeast food supplements Speaker: Francesca Menniti Ippolito (Italy) |
||
| 17:45 - 18:00 | Discussion | ||||
| 19:30 | Meeting Dinner | ||||
Conference day 3 - Friday, 30 October 2015
| Zenit | Nadir | ||||
| 09:00 - 10:30 |
Parallel
session I Hot topics around the cube (selection of the best abstracts) Chairs: Gaby Danan (France), Petra Matoulková (Czech Republic) |
09:00 - 10:30 |
Parallel
session J New methodologies in Signal detection and Safety surveillance Chairs: Andrew Bate (UK), Radek Běla (Czech Republic) |
||
| 09:00 - 09:30 |
O 43:
Drug-Induced Liver Injury: Where Are We in 2015? Speaker: Gaby Danan (France) |
09:00 - 09:30 |
O 47:
Multivariate Analysis for Visualizing Pharmacovigilance Data Speaker: Manfred Hauben (USA) |
||
| 09:30 - 09:45 |
O 44:
Cohort study of blood dyscrasias associated with the use of proton pump
inhibitors (PPIs) Speaker: Carmen D'Amore (Italy) |
09:30 - 09:50 |
O 48:
WEB-RADR: Use of mobile technologies and social media in
pharmacovigilance Speaker: Phil Tregunno (UK) |
||
| 09:45 - 10:00 |
O 45:
Effect of glyburide compared with other second-generation sulfonylureas
on the risk of cancer in patients with type 2 diabetes mellitus Speaker: Marco Tuccori (Italy) |
09:50 - 10:10 |
O 49:
Tuning epidemiological study design methods for exploratory data
analysis in real world data Speaker: Andrew Bate (UK) |
||
| 10:00 - 10:15 |
O 46:
Challenges of evaluating the safety profile of non-active implantable
medical devices compared to medicinal products Speaker: Josep Pané (Spain) |
10:10 - 10:20 |
O 50:
Spontaneous reports and electronic health records for safety signal
detection – yin and yang Speaker: Alexandra Pacurariu (The Netherlands) |
||
| 10:15 - 10:30 | Discussion | 10:20 - 10:30 |
O 51:
Adverse event cluster analysis for syndromic surveillance Speaker: Rebecca Chandler (Sweden) |
||
| 10:30 - 11:00 | Coffee Break | ||||
| 11:00 - 11:30 |
Keynote
Lecture 4
Chair: Jiří Vlček (Czech Republic) O 52: Role of Genomics in Pharmacovigilance Speaker: Ondřej Slanař (Czech Republic) |
||||
| 11:30 - 13:00 |
Bengt
Erik Wiholm Lecture
O 53: Patient safety through dialogue – how to better connect pharmacovigilance and healthcare? Chairs: Priya Bahri (UK), Brian Edwards |
||||
| 11:30 - 11:40 |
O 54:
Healthcare professionals’ perspectives on regulatory safety
communication about medicines: The Strengthening Collaboration for
Operating Pharmacovigilance in Europe (SCOPE) Joint
Action
Speaker: Peter Mol (The Netherlands) |
||||
| 11:40 - 11:50 |
O 55:
Overview on risk communication in EU - Highlights from Croatia as
regional example
Speaker: Viola Macolić Sarinić (Croatia) |
||||
| 11:50 - 12:00 |
O 56:
Talking about harm and benefit information – the challenges in
healthcare practice
Speaker: DK Theo Raynor (UK) |
||||
| 12:00 - 12:10 |
O 57:
Risk factors, psychology and communication
Speaker: Hansjörg Neth (Germany) |
||||
| 12:10 - 13:00 | Round-table / Panel discussion | ||||
| 13:00 - 13:15 | Poster Prize Ceremony | ||||
| Closing Ceremony of ISoP 2015 | |||||
| 13:15 - 14:15 | Light lunch | ||||
Meeting Secretariat: C-IN, 5. kvetna 65, 140 21 Prague 4, CZE | tel.: +420 261 174 301 | fax: +420 261 174 307
Home | Sitemap | info@isop2015prague.org
Copyright © 2014 isop2015prague.org | Powered and created by E-WORKS - web studio | XHTML 1.0 | CSS 2
Home | Sitemap | info@isop2015prague.org
Copyright © 2014 isop2015prague.org | Powered and created by E-WORKS - web studio | XHTML 1.0 | CSS 2